Medical network, June 7, June 5, national health development planning commission issued a "about implementation about the disease to clinical pathway, and 202 kinds of clinical pathway to come. At this point, the national clinical pathway program has reached 1212. Along with the advance of health care reform, these clinical pathways will have a huge impact on medical equipment, medical consumables, and diagnostic reagents in hospital sales in the future. 

 

The health development planning commission is entrusted the Chinese medical association organization expert system (repair) order 23 professional 202 kinds of clinical pathway, for the family planning administrative department of public health and medical institutions. With 1,010 clinical paths issued by the national health and family planning commission six months ago, the national clinical pathway has reached 1,1212. 

 

In the past, hospitals are often in accordance with the project fee, this has led to the hospital, doctors tried every means to much charge from the diagnosis and treatment projects, that appear more prescriptions, expensive medicine, do more inspection, do more big check phenomenon, serious harm the interests of patients, has become a national health insurance funds of black holes. 

 

And the current health care reform direction is clear, which is from project membership dues to press macro-reforms, finally to pay by disease diagnosis related group (DRGs) change of the pattern. 

 

In this context, the patient suffers from a disease and the health insurance pays a fixed fee. The department of medical industry, for example, has a clinical path plan that requires doctors to conduct clinical practice in accordance with the clinical path plan. 

 

Patients want to buy medicine, want to do more check, want to change a few gauze bandaging under no, every time you open a box of medicine, a box of medicine hospital will loss of money. Hospitals and hospitals can prescribe fewer medicines and less tests. 

 

As a result, a lot of equipment, consumables, reagents will undoubtedly become redundant, or the dosage is greatly reduced. And those that do not have access to the clinical pathway are likely to lose a lot of hospital market share. 

 

Doctors will have a new way of examination, the hospital profit, most of the rewards can be used for personnel, the sunshine doctors lawful income will increase, such as kickbacks phenomenon will be reduced, not the "weapon", would you?